Birth Control Center

Birth Control Care Center abortion clinic in Las Vegas, Nevada.

Alternatives Salon

Alternatives Salon is a leader among hair salons in Stroudsburg, PA, highly recognized for providing the best in natural hair care and expert makeup services.

HPR Cro GmbH

HPR -CRO GmbH – a Contract Research Organization (CRO) – has built a successful name in human pharmacodynamic research starting in 1976. Since more than 40 years, HPR - Human Pharmacodynamic Research, founded by Dr. med. Klaus Schaffler, MD, has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in human experimental pain research. In this period over 175 presentations/publications more than 150 phase-I studies with quite different objectives have been conducted, outlining medication onset, pain relief and providing insights into adverse effects objectively and subjectively. HPR is focused on Phase-I clinical trials in human pharmacodynamics and in combined pd/pk approaches for national and international pharmaceutical companies. Hereby, HPR has elaborated – besides other CNS-research approaches in vigilance and psychomotorics – a special model, the "Laser-Pain-Algesimetry", under consideration of different sensitized and non-sensitized states of the skin to examine and analyze the effect of analgesic and anti-inflammatory compounds in humans. This well-developed and validated method of pain measurement guarantees a highly objective and quantitative approach to investigate the efficacy of analgesics by examining brain responses to repetitive nociceptive stimuli via "Evoked Potentials" – recorded on-line in real-time from Vertex-EEG position. This strong, unique and systematic methodological feature, together with flexible and creative study designs, as well as quick statistical data analysis and reporting, enables us to provide customers with outstanding examination and analysis of medication effects on CNS and pain processing – also based on an existing large data base of prior investigated analgesics and topicals (>50 !) in different compound groups and also based on a large scale of experimental and practical trial experience and competence in this field.

Circadian Technologies Limited

Circadian Technologies Limited (ASX: CIR) is an Australian biotechnology company focused on the development of biologics-based therapies for the treatment of cancer and eye disease. Circadian owns an extensive patent portfolio covering targets (VEGF-C, VEGF-D, VEGFR-3) and drugs (VGX-100 and VGX-300) to modulate the processes of angiogenesis - the development of blood vessels within the body and lymphagiogenesis-the development of lymphatics in the human body. Circadian's product pipeline includes biologics drugs targeting important mediators of angiogenesis and lymphangiogenesis. Circadian's lead development candidate, VGX-100, is a fully human antibody that inhibits the VEGF-C protein. VGX-100 is currently in Phase 1a and Phase 1b clinical trials in late stage cancer patients at 2 leading US cancer centres. These studies are being done under an IND. Phase 2 studies are expected to commence in H2 2013. VGX-100 and VGX-300 are also being developed as agents to treat age related macular degeneration in patients non-responsive to anti-VEGF-A therapy. VEGF-C and VEGFR-3 have been shown to play a major role in retinal angiogenesis. VGX-100 and VGX-300 have been shown to be effective in animal models of back of the eye disease. They are currently in pre-clinical development with clinical development expected to commence by H1 2014.

Faséo

Faséo est bureau d'études créé par Benoît Géhin le 25 mars 2005 qui se base sur l'expérience de son dirigeant, lequel avait alors plus de quinze années d'expérience sur les chantiers et au sein de bureaux d'études. Faséo s'appuie aussi sur les énergies complémentaires d'une équipe d'ingénieurs, de techniciens, de projeteurs et de dessinateurs chacun experts dans leurs spécialités respectives. Depuis bientôt 12 ans, Faséo a su gagner la confiance de ses clients concernant l'ingénierie de leurs projets. Que ce soient de la maitrise d'œuvre, de l'assistance techniques, des études de faisabilité, des créations de cahier des charges, des dossiers de consultation, des évaluations de budget, des analyses techniques et financières des offres ou l'exécution des différents plans ou schémas, Faséo a su accompagner ceux qui lui ont fait confiance. Mais Faséo est surtout une entreprise dynamique qui cherche sans cesse à adapter son savoir-faire à l'évolution rapide de l'univers du bâtiment. Initialement bureau d'études en électricité, nous avons rapidement su évoluer avec les progrès actuels en travaillant par exemple sur des projets tous fluides, en apprenant à maîtriser la gestion technique (domotique, GTB et GTC) et les énergies renouvelables. Soucieux de la trace que nous laisserons, nous cherchons toujours à favoriser des solutions respectueuses de l'environnement.